SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+3.51%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$214M
AUM Growth
+$214M
(-20%)
Cap. Flow
-$56.5M
Cap. Flow
% of AUM
-26.34%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
81
New
12
Increased
14
Reduced
26
Closed
20
Top Buys
| 1 |
Cardinal Health
CAH
|
$5.01M |
| 2 |
Thermo Fisher Scientific
TMO
|
$4.13M |
| 3 |
Revvity
RVTY
|
$3.41M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$3.03M |
| 5 |
Bio-Techne
TECH
|
$3.02M |
Top Sells
| 1 |
Cigna
CI
|
$6.09M |
| 2 |
HCA Healthcare
HCA
|
$5.82M |
| 3 |
CELG
Celgene Corp
CELG
|
$5.22M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$4.46M |
| 5 |
Johnson & Johnson
JNJ
|
$4.19M |
Sector Composition
| 1 | Healthcare | 95.03% |
| 2 | Energy | 1.01% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Abbott
ABT
$231B
| $8.09M | 3.77% |
135,000
+25,000
| +23% | +$1.5M |
|
2
Humana
HUM
$36.5B
| $8.07M | 3.76% |
30,000
+5,000
| +20% | +$1.34M |
|
3
UnitedHealth
UNH
$281B
| $7.49M | 3.49% |
35,000
| – | – |
|
4
AbbVie
ABBV
$372B
| $7.1M | 3.31% |
75,000
+10,000
| +15% | +$947K |
|
5
Centene
CNC
$14.3B
| $6.85M | 3.2% |
64,124
-5,876
| -8% | -$628K |
|
6
Viatris
VTRS
$12.3B
| $6.59M | 3.07% |
160,000
+40,000
| +33% | +$1.65M |
|
7
Universal Health Services
UHS
$11.6B
| $6.51M | 3.04% |
55,000
-5,000
| -8% | -$592K |
|
8
Baxter International
BAX
$12.7B
| $6.5M | 3.03% |
100,000
| – | – |
|
9
Molina Healthcare
MOH
$9.8B
| $6.49M | 3.03% |
80,000
-20,000
| -20% | -$1.62M |
|
10
Teva Pharmaceuticals
TEVA
$21.1B
| $6.07M | 2.83% |
355,000
+80,000
| +29% | +$1.37M |
|
11
Vertex Pharmaceuticals
VRTX
$100B
| $5.7M | 2.66% |
35,000
-10,000
| -22% | -$1.63M |
|
12
Stryker
SYK
$150B
| $5.63M | 2.63% |
35,000
+5,000
| +17% | +$805K |
|
13
Intuitive Surgical
ISRG
$170B
| $5.16M | 2.41% |
12,500
-1,500
| -11% | -$619K |
|
14
Bristol-Myers Squibb
BMY
$96B
| $5.06M | 2.36% |
80,000
+5,000
| +7% | +$316K |
|
|
15
Cardinal Health
CAH
$35.5B
| $5.01M | 2.34% |
+80,000
| New | +$5.01M |
|
16
Boston Scientific
BSX
$156B
| $4.78M | 2.23% |
175,000
-15,000
| -8% | -$410K |
|
17
Illumina
ILMN
$15.8B
| $4.73M | 2.21% |
20,000
+5,000
| +33% | +$1.18M |
|
18
Align Technology
ALGN
$10.3B
| $4.52M | 2.11% |
18,000
+2,000
| +13% | +$502K |
|
19
Elevance Health
ELV
$71.8B
| $4.39M | 2.05% |
20,000
-10,000
| -33% | -$2.2M |
|
|
WCG
20
DELISTED
Wellcare Health Plans, Inc.
WCG
| $4.25M | 1.98% |
21,967
-13,033
| -37% | -$2.52M |
|
|
21
Thermo Fisher Scientific
TMO
$186B
| $4.13M | 1.93% |
+20,000
| New | +$4.13M |
|
22
Biogen
BIIB
$19.4B
| $4.11M | 1.92% |
15,000
-5,000
| -25% | -$1.37M |
|
|
EVHC
23
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $4.04M | 1.88% |
105,000
+20,000
| +24% | +$769K |
|
24
Smith & Nephew
SNN
$16.3B
| $3.82M | 1.78% |
100,000
+5,000
| +5% | +$191K |
|
25
Bio-Rad Laboratories Class A
BIO
$8.06B
| $3.75M | 1.75% |
15,000
+2,500
| +20% | +$625K |
|